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Abstract
Background: Little is known about expression and function of the somatostatinergic system in the mammalian
cochlea. We have previously shown that somatostatin administration may have a protective effect on gentamicin-
induced hair cell loss. In this study, we have analyzed the cochlear expression of somatostatin receptor 1 (SST1)
and somatostatin receptor 2 (SST2) at both the mRNA and the protein level in wild-type mice, as well as in SST1
and SST2 knock-out (KO) mice and in cultivated neurosensory cells.
Results: We demonstrate that the somatostatin receptors SST1 and SST2 are specifically expressed in outer and
inner hair cells (HCs) of the organ of Corti (OC), as well as in defined supporting cells. The expression of SST1 and
SST2 receptors in cultivated P5 mouse OC explants was similar to their expression in inner and outer hair cells.
Somatostatin itself was not expressed in the mammalian cochlea, suggesting that somatostatin reaches its
receptors either through the blood-labyrinthine barrier from the systemic circulation or via the endolymphatic duct
from the endolymphatic sac. We used mice with a deletion of either SST1 or SST2 to learn more about the
regulation of SST1 and SST2 receptor expression. We demonstrate that in SST1 KO mice, SST2 was expressed in
outer HCs and Deiters’ cells, but not in pillar cells or inner HCs, as compared with wild-type mice. In contrast, in
SST2 KO mice, the expression pattern of the SST1 receptor was not altered relative to wild-type mice.
Conclusions: These findings reveal that somatostatin receptors demonstrate specific expression in HCs and
supporting cells of the mouse cochlea, and that absence of SST1 alters the expression of SST2. This specific
expression pattern suggests that somatostatin receptors may have important functional roles in the inner ear.
Background
Somatostatin, also known as somatotropin release-inhibit-
ing factor (SRIF), is mainly produced by endocrine, gastro-
intestinal, immune, and neuronal cells, as well as by
certain tumors. Somatostatin is widely distributed
throughout the central nervous system (CNS) and periph-
eral tissues in mammals [1]. The discovery of somatostatin
receptor subtypes triggered in-depth research into their
binding properties and their coupling to multiple signaling
pathways. Somatostatin acts via a family of G-protein-
coupled receptors known as somatostatin receptors 1-5
(SST1 - SST5), which are differentially distributed
throughout the CNS [2]. Signaling through somatostatin
receptors is complex and involves auto-, para-, or
endocrine mechanisms [3-8]. Binding of somatostatin to
its receptors induces G-protein activation through various
pathways, resulting in the activation of several key
enzymes, including adenylyl cyclase, phosphothyrosine
phosphatase (PTPase) and mitogen activated protein
kinase (MAPK) are modulated, along with changes in the
intracellular levels of calcium and potassium ions [9].
Studies over the last few years in mice have shown
that somatostatin and its receptors appear to play an
important role in cell death. In a retina ischemia model,
activation of the SST2 receptor protected retinal neu-
rons from damage [10]. Additionally, studies in mice
with genetic alterations of the somatostatinergic system
revealed that an increased presence of functional SST2
receptor protected against retinal ischemia [11]. There-
fore, SST2 analogues might be of therapeutic benefit in
retinal diseases [12-14].
However, in contrast to the situation in the retina, less
is known regarding the expression or function of
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bana et al. reported on somatostatin-like immunoreac-
tivity in the medial geniculate body, cochlear nucleus,
inferior colliculus, auditory cortex, and cochlea, but did
not find somatostatin-like immunoreactivity in the
cochlear perilymph [15]. Somatostatin-like immunoreac-
tivity has also been observed in the cochlear nuclei of
postnatal rats and it has been suggested that somatosta-
tin might be important for the development of the audi-
tory system [16]. In an additional study, somatostatin-
producing cells were observed in the covering epithe-
lium of the spiral prominence and in the epithelium of
the intermediate and rugosal part of the endolymphatic
sac [17,18]. In a recent publication from our group, we
demonstrated expression of SST1 and SST2 mRNA in
the postnatal rat cochlea and we reported on a dose-
dependent protective effect of somatostatin on gentami-
cin-induced HC loss in vitro [19].
In the present study, we have analyzed the cochlear
expression of SST1 and SST2 at both the mRNA and
protein level in wild-type mice, as well as in SST1 and
SST2 KO mice and in cultivated neurosensory cells.
Results
SST1 and SST2 mRNAs are expressed in the cochlea
We performed real-time PCR to determine the quantita-
tive gene expression of SST1 and SST2 in in the OC of
0-, 5-, 10-, 14-, and 21-day-old wild-type mice. Expres-
sion of SST1 is significantly increased in OC explants
from P5, P10, P14 and P21 day-old-mice compared to
the expression in OC explants from P0 mice (Figure 1).
As shown in Figure 1, SST2 mRNA appeared to be
expressed at a low level in the cochlea of P0, P5, and
P10 mice. The expression of SST2 in OC explants from
P14 and P21 old wild-type mice is significantly increased
as compared to expression in OC explants from P0, P5
and P10 mice.
SST1 and SST2 expression in wild-type and KO mice
Immunohistochemistry was performed to localize SST1
and SST2 protein in the adult mouse cochlea. Cochlear
tissue sections were stained with SST1 and SST2 antibo-
dies, respectively; cell nuclei were stained blue with
DAPI. Immunostained sections were analyzed by confo-
cal microscopy.
Cochlear SST1 and SST2 protein expression in adult mice
SST1 immunoreactivity was observed in outer and inner
HCs, in outer and inner pillar cells, and in the spiral
ganglion (SG) (Figure 2A and 2B). The strongest immu-
noreactivity was observed in the apical part of the outer
and inner HCs (Figure 2B), and weaker staining was
present in the basal part of the HCs and the pillar cells.
Double labeling with the neurofilament marker SMI31,
which stains axons, revealed that the axons connecting
the SG with the OC do not express SST1 (Figure 2D)
SST1 immunostaining was completely absent in the
SST1 KO mice, confirming the specificity of the antibo-
dies used (Figure 2C).
SST2 immunoreactivity was observed in the OC (Fig-
ure 3A), namely in the inner and outer HCs, the inner
and outer pillar cells, and at the membrane of Deiters’
cells (Figure 3B and 3D). Staining intensity appeared to
be strongest in the pillar cells and Deiters’ cells and less
Figure 1 SST1 and SST2 cochlear gene expression in OC
explants, P0-P21. The relative distribution of SST1and SST2 mRNA
expression in OC tissue from wild-type mice of different postnatal
ages was quantified by real-time PCR. GAPDH served as an
endogenous control. Gene expression levels are expressed as mean
(± S.E.) fold increase as compared with values obtained in OC
explants from P0 mice. Data were obtained from 5 independent
experiments. Statistical analysis was performed using the ANOVA
test followed by the Bonferroni post-hoc test. *, p < 0.02; **, p <
0.0002; ***, p < 0.00001.
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Page 2 of 12Figure 2 SST1 in the adult mouse cochlea. A, overview, SST1
(red) can be observed in the OC and SG; cell nuclei (DAPI) are in
blue. B, SST1 (red) can be detected in outer HCs, inner HCs, and
outer and inner pillar cells. C, D, labeling with the neurofilament
marker SMI31 (green) demonstrates that cochlear afferent neurons
(CANs), which connect the SG with the OC, do not express SST1;
cell nuclei (DAPI) are in blue. (A) Image by immunofluorescence
microscopy, scale bar = 50 μm. (B-D) Images by confocal
microscopy, scale bar = 25 μm.
Figure 3 SST2 in the adult mouse cochlea. A, overview, SST2
(red) can be observed in the OC and the SG; cell nuclei (DAPI) are
in blue. B-C, SST2 (red) can be detected in outer HCs, inner HCs,
and the membrane of Deiters’ cells, as well as in outer and inner
pillar cells. D, labeling with the neurofilament marker SMI31 (green)
demonstrates that cochlear afferent neurons (CANs), which connect
the SG with the OC, do not express SST2; cell nuclei (DAPI) are in
blue. (A) Image by immunofluorescence microscopy, scale bar = 50
μm. (B-D) Images by confocal microscopy, scale bar = 25 μm.
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Page 3 of 12strong in outer and inner HCs. SMI31-positive axons
from the spiral ganglion were SST2-negative (Figure
3D). SST2 immunostaining was completely absent in the
SST2 KO mice, confirming the specificity of the antibo-
dies used (Figure 3C).
Cochlear SST2 protein expression in adult SST1 receptor KO
mice
No SST1 antibody staining was observed in the cochlea
of SST1 KO mice, indicating the complete absence of
SST1 protein in this mouse model and confirming the
specificity of the antibody used (Figure 4A). SST2 pro-
tein (Figure 4B and 4D) was strongly expressed in Dei-
ters’ cells, and to a lesser extent in outer HCs, but was
absent from pillar cells and inner HCs compared with
wild-type mice (Figure 3B). This expression pattern of
SST2 in SST1 receptor KO mice was observed in all of
the sections analyzed (n = 20 sections analyzed per KO
mouse).
Cochlear SST1 protein expression in adult SST2 receptor KO
mice
No SST2 antibody staining was observed in the cochlea
of SST2 KO mice, indicating the complete absence of
SST2 protein in this mouse model and confirming the
specificity of the antibody used (Figure 4E). SST1 pro-
tein (Figure 4F and 4H) was expressed in outer and
inner HCs, as well as in supporting cells. The overall
staining pattern did not differ from that of wild type
mice (compare Figure 2B).
SST1 and SST2 protein are expressed in OC explants
To determine whether SST1 and SST2 were expressed
in OC explants prepared from postnatal mice, we dou-
ble-stained OC explant tissue with phalloidin and either
SST1 or SST2 antibodies (Figure 5). Phalloidin staining
reveals that the cytoarchitectonic organization of the
OC is maintained, and inner HCs and the three outer
layers of HCs can be identified (Figure 5A and 5D).
Both SST1 and SST2 were most strongly expressed in
inner HCs; however, weak immunoreactivity was also
present in the outer HCs (Figure 5B, C, E, and 5F).
SST1 and SST2 protein expression in passaged
neurosensory cells derived from the cochlea
Immunocytochemistry was performed to localize SST1
and SST2 protein on passaged neurosensory cells from
the immature cochlea. Myosin VII served as a marker
for HCs, and cell nuclei were stained in blue with DAPI.
SST1 and SST2 were detected in the Myosin VII-posi-
tive neurosensory cells and were mainly localized in the
p e r i n u c l e a rr e g i o n( F i g u r e6 C ,D ,G ,a n d6 H ) .L a b e l i n g
of the plasma membrane was weak or undetectable in
the cultured cells, suggesting that most receptors were
not inserted into the plasma membrane.
Cochlear expression of somatostatin
Immunohistochemistry was performed to localize
somatostatin in the adult mouse cochlea. Cochlear tis-
sue sections were stained with somatostatin antibodies.
No somatostatin immunoreactivity was observed in the
cells of the cochlea (Figure 7A and 7B). The label in
the tectorial membrane is likely to reflect unspecific
staining. Somatostatin was detected in the brain via
Western blotting (positive control) (Figure 7E). In the
brain sample, we observed bands at 1,600 Da, 17,000
Da (corresponding to somatostatin 14), 28,000 Da, and
38, 000 Da (corresponding to somatostatin 28). We
were unable to detect somatostatin in protein extracts
from the OC, SG, or SV. These results suggest that
somatostatin is not produced in the mammalian
cochlea.
Discussion
In the present study, we demonstrate that the somatos-
tatin receptors SST1 and SST2 are expressed in outer
and inner HCs of the OC, as well as in defined sup-
porting cells. We also demonstrate that in SST1 KO
mice, SST2 is strongly expressed in Deiters’ cells and
o u t e rH C s ,b u tn o ti np i l l a rc e l l so ri n n e rH C sc o m -
pared with wild-type mice. In contrast, in SST2 KO
mice, the expression pattern of SST1 receptor is not
altered compared with wild-type mice. Finally, we pro-
vide evidence that somatostatin is not produced in the
cochlea itself.
Localization of SST1 and SST2 receptors in the inner ear
At present, very little is known about the expression of
SST1 and SST2 receptors in the inner ear. Our findings
demonstrate that SST1 and SST2 receptor mRNA is
expressed in the mammalian cochlea. Furthermore, we
were able to localize the expression of both receptors in
the cochlea using immunohistochemistry. We show that
SST1 and SST2 receptors are present specifically in
HCs, as well as in supporting cells of the OC of the
adult mouse, with SST1 being more prominent in HCs
and SST2 being more prominent in supporting cells.
Both receptors were present in the SG. It is noteworthy
that SST1 and SST2 m RNA expression increases post-
natal, and peaks at P14. Brain stem electrical response
audiometry (BERA) cannot be recorded before P12-P14
in mice. It might be possible that SST1 and SST2 are
necessary for the growth and development of the OC
but not for later maturation of hearing. The SST1 and
SST2 receptor proteins are also expressed in passaged
cochlear neurosensory cells derived from postnatal
mouse OC. In the future, in vitro experiments such as
calcium influx assays would be useful to test somatosta-
tin function.
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Page 4 of 12Figure 4 Cochlear SST1 and SST2 localization in SST1 and SST2 KO mice. A, E, SST1 (A, red) cannot be detected in the SST1 KO mouse
cochlea, and SST2 (E, red) cannot be detected in the SST2 KO mouse cochlea (negative controls). B, F SST2 (B, red) is expressed in outer HCs
and Deiters’ cells in the SST1 KO cochlea, while SST1 (F, red) is expressed in outer and inner HCs, as well as in supporting cells in the SST2 KO
cochlea. C, G, Cell nuclei (DAPI, blue) and calbindin staining (green) in cochleae from SST1 KO (C) and SST2 KO (G) mice. D, H, Composite
images of cochleae from SST1 KO (D) and SST2 KO (H) mice. Images by confocal microscopy; scale bar = 100 μm.
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Page 5 of 12Neuroprotective role of SST1 and SST2 receptors in the
inner ear
The function of these two receptors in the OC is cur-
rently unknown. However, we have recently demon-
strated that somatostatin can protect HCs from
aminoglycoside toxicity in a dose-dependent manner in
vitro [19]. It is reasonable to assume that this neuropro-
tective effect of somatostatin on HCs was mediated by
SST1 or SST2 receptors; however, this has not yet been
experimentally proven. Nevertheless, our findings are
consistent with a neuroprotective role for the somatos-
tatin signaling system with respect to auditory HCs.
In contrast to the situation in the inner ear, more is
known about the expression and neuroprotective role of
the somatostatinergic system in the retina. It has been
demonstrated that somatostatin and its receptors (SST1-
SST5) are expressed in the retina, predominatly in ama-
crine cells and bipolar cells [14,20]. Moreover, activation
of the somatostatin receptor SST2 by somatostatin or its
analogues has been shown to protect retinal neurons
against ischemia-induced damage [10]. In addition, stu-
dies in mice with genetic alterations of the somatostati-
nergic system have revealed that an increased presence
of functional somatostatin receptor SST2 protects
against retinal ischemia [11]. Therefore, SST2 analogues
might be of therapeutic benefit in retinal diseases such
as glaucoma or diabetic retinopathy, but may also pro-
tect from hearing loss due to HC degeneration and
death.
What are the molecular mechanisms involved in the
protection of cells from death by somatostatin and its
analogues? Studies in mouse retinal explants have
demonstrated that the SST2 receptor inhibits potas-
sium-induced glutamate release [21]. By limiting the
amount of glutamate available to glutamate receptors,
somatostatin and its analogues may exert a neuroprotec-
tive function against glutamate neurotoxicity, which
characterizes many retinal diseases [1]. Glutamate exci-
totoxicity appears to be mediated by the activation of
caspase-3, as shown in cerebrocortical neurons [22].
Glutamate excitotoxicity is also involved in HC damage
and death in the cochlea [23]. Therefore, somatostatin
may protect HCs from aminoglycoside toxicity, either by
limiting glutamate release or by mitigating the toxic
action of excess glutamate on HCs. In this context, it is
notable that the somatostatin analogue octreotide alters
the activity of the phosphatidylinositol 3-kinase pathway
[24] in pituitary tumor cells. We demonstrated recently
that the phosphatidylinositol 3-kinase pathway is
involved in NF-kappaB-dependent HC survival [25].
Figure 5 SST1 and SST2 expression in OC explants. A, D, phalloiding staining (green) of OC explants. B, E, immunoreactivity of both SST1
and SST2 (red) was stronger in inner than in outer HCs of OC (arrow). C, F, Respective combined images of phalloidin (green) with SST1 and
SST2 (red) confirm that the inner and outer HCs in cultivated OC express SST1 and SST2. Images by immunofluorescence microscopy; scale bar
=5 0μm.
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Page 6 of 12Therefore, it might be possible that somatostatin exerts
its effect on HCs through the phosphatidylinositol 3-
kinase survival pathway.
Absence of somatostatin in the cochlea
Using immunohistochemistry and Western blotting, we
were unable to detect somatostatin within the mamma-
lian cochlea. Because we show the expression of somatos-
tatin receptors within the cochlea, the following question
arises: how can somatostatin reach its receptors? One
possibility would be that somatostatin production is
induced only upon excitotoxic challenge or other adverse
signals. However, somatostatin immunoreactivity has
been observed in the endolymphatic sac [18]. Therefore,
it might be possible that somatostatin is produced in the
endolymphatic sac and reaches the cochlea through the
endolymphatic duct. Another possibility might be that
somatostatin crosses the blood-labyrinthine barrier, and
so somatostatin within the blood could reach the cochlea.
It has been demonstrated that octapeptide analogs of
somatostatin can cross the blood-brain barrier via a
saturable transport system [26]. A similar transport sys-
tem might be responsible for the transport of somatosta-
tin into the cochlea via the blood-labyrinthine barrier.
Figure 6 Detection of SST1 and SST2 in passaged neurosensory cells from mouse cochleae. A, E, cell nuclei (DAPI) are depicted in blue. B,
F, the cell membrane of the cultivated cells is positive for the HC marker myosin VII (green). C, G, perinuclear localization of SST1 (C, red) and
SST2 (G, red) are detected in cultivated cells. D, H, composite images. Images by immunofluorescence microscopy; scale bar = 50 μm.
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Page 7 of 12Figure 7 Detection of somatostatin in the wild-type mammalian cochlea. A, B, somatostatin (red) cannot be detected in the cochlea of WT
animals, although there is positive somatostatin staining on the tectorial membrane (B, TM); cell nuclei (DAPI) are in blue, and calbindin staining
is in green. C, D, somatostatin-positive staining (red) is evident in the cortex and hypothalamus of WT mouse brain. E, Western blotting reveals
that somatostatin can only be detected in protein extracts from brain tissue (positive control) but not in extracts from the OC, SV or SG. Actin
serves as a standard to demonstrate that equal amounts of proteins have been loaded. Images by immunofluorescence microscopy; scale bar =
50 μm (A, C) or 25 μm (B, D).
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Page 8 of 12SST1 KO mice: loss of SST1 receptors
In the inner ear, there is no information available on the
consequences of SST1 receptor deletion in mice. In the
cochlea of SST1 KO mice, SST1 protein was completely
absent. This result is consistent with the SST1 gene
being completely inactivated [27], and confirms the spe-
cificity of the antibody used. Our data demonstrate that
in the mouse cochlea, SST1 receptor loss has a major
effect on the expression of SST2 receptors: while in
wild-type mice SST2 could be observed in outer HCs,
inner HCs, and supporting cells (and most prominently
in outer and inner pillar cells), in SST1 KO mice the
SST2 receptor was observed only in outer HCs and cells
supporting the outer HCs, but not in pillar cells or
inner HCs. Notably, a similar observation has been
made in the mouse retina: SST1 receptor loss resulted
in a pronounced increase of SST2 receptor expression
[21]. Among other possibilities, the authors of this study
speculated that the SST1 receptor might directly regu-
late SST2 receptor expression. Our findings demonstrate
prominent compensatory regulation in the mammalian
cochlea as a consequence of a distinct somatostatin
receptor deletion. This compensatory mechanism is sub-
type-specific, as it is observed only after the deletion of
SST1, and not after the deletion of SST2.
SST2 KO mice: loss of SST2 receptors
SST2 protein was undetectable in the cochlea of SST2
KO mice. This result is in agreement with the complete
inactivation of the responsible gene [27], and also con-
firms the specificity of the antibody used. In contrast to
SST1 KO mice, SST2 receptor loss has no effect on the
expression of the SST1 receptor in the inner ear. In
wild-type mice as well as in SST2 KO mice, the SST1
receptor was detected in outer and inner HCs, as well
as in supporting cells. This finding is in agreement with
observations in other cellular systems where no such
compensatory effect was observed following the knock-
out of a somatostatin receptor. For example, in the
brain of SST2 KO mice, little effect has been observed
on the expression of SST1 and SST3-5 [28].
Conclusions
The presence of somatostatin receptors within the
mammalian cochlea, their specific expression in the OC,
and their subtype-specific compensatory regulation as a
consequence of distinct somatostatin receptor deletion
suggest an important role for the somatostatinergic sys-
tem within the inner ear.
Methods
Animals
Experiments were performed on mouse cochleae from
wild-type (WT) C57BL/6 mice of both sexes, in the
adult (n = 5) and during postnatal (n = 10/postnatal
day) development. Immunohistochemstry was also per-
formed on cochleae from adult SST1 (n = 4) or SST2 (n
= 4) KO strains of both sexes. An SST1 null allele was
generated by deleting the entire SST1 coding region,
targeted and maintained in a hybrid129/Sv: C57BL/6
background [29]. The WT and homozygous SST2 KO
mice [27,30] were backcrossed into the C57BL/6J
genetic background for thirteen generations.
All animal procedures were conducted in conformity
with the European Communities Council Directive of 24
November 1986 (86/609/EEC) and were reviewed and
permitted by the Kantonales Veterinäramt, Basel,
Switzerland.
Dissociation and cultivation of HCs
The cochleae of 6-day-old mice were dissected to isolate
the OC [31]. The OC was placed in preparation medium
(PM) consisting of DMEM (Gibco-Invitrogen, Switzer-
land) with 25 mM HEPES (Gibco-Invitrogen, Switzer-
land), 6 mg/ml glucose, 30 U/ml penicillin, and 30 ml/
ml N-2 supplement (Cell Concepts, Switzerland) at pH
7.3. The tissue was cut into 2-mm cubes and transferred
to a sterile 15-ml tube. Dissected tissue pieces were
rinsed twice in PM and trypsinized for 15-20 min at 37°
C. Trypsinization was stopped by the addition of horse
serum (one-quarter volume) and DNase (0.01%). The
cells were then centrifuged for 5 min at 600 g at room
temperature. The pellet containing 100,000 cells/ml was
resuspended, and cells were plated onto poly-L-lysine-
coated cultured dishes for 7 days. Culture dishes were
coated with 50-100 μLo f1 0μg/mL poly-D-lysine, and
pretreated with 10% heat-inactivated FCS for 2 hours.
The cells were seeded at a density of 0.5-1.0 × 10
6 cells/
cm
2 and incubated in complete growth medium, which
consisted of PM and the brain-derived neurotrophic fac-
tor (10 ng/mL). Trypan blue exclusion indicated that
this preparation consisted of 87-98% viable cells.
For passaging, cells were dissociated mechanically and
were resuspended in the same medium at a density of
50,000 cells/ml. The cells were then passaged 10 times
and subsequently analyzed by immunocytochemistry.
OC explant cultures
OC explants were prepared and cultivated according to
as detailed by Sobkowicz et al. [32]. Neonatal (P5, n =
20) wild-type mouse pups were rapidly decapitated.
After removing the brains and the temporal bones, the
cochleae were microdissected, and the OC, SG, and SV
were isolated. After isolation, all OCs were separated,
placed on Millicell-CM 0.4-μm culture plates (Millipore,
Austria) in 24-well dishes, and were maintained in cul-
ture medium at 37°C in a humidified CO2-enriched
atmosphere for a minimum of three days to allow tissue
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Page 9 of 12recovery from explantation trauma. The medium con-
sisted of DMEM with 25 mol/l HEPES, supplemented
with 10% fetal calf serum (Invitrogen, Carlsbad, CA),
and 30 U/ml penicillin (Sigma) adjusted to pH 7.3.
RNA extraction
Twenty OCs from wild-type mouse pups aged P0-P21
were placed separately in RNAlater (Qiagen, Hombrech-
tikon, Switzerland). RNA isolation of the brains and the
inner ear components were performed using the
RNAeasy Minikit (Qiagen) and employing a Ultra-Tur-
rax T8 tissue homogenizer (IKA-Werke, Staufen, Ger-
many) according to the manufacturer’si n s t r u c t i o n s ,
including DNAse treatment. The quantity and quality of
isolated RNA were determined with NanoDrop ND
1000 (NanoDrop Technologies, Delaware, USA). The
260/280-nm ratio of all samples was between 1.8 and
2.1
Real-time PCR
Total RNA (500 ng) was reverse transcribed into cDNA
with the First Strand cDNA synthesis kit (Roche Applied
Biosciences) according to the manufacturer’si n s t r u c -
tions. The reaction took place in an ABI Prism 7900HT
Sequence Detection System (Applied Biosystems) using
a Fast Start Universal SYBR Green Master (Rox) (Roche
Applied Biosciences Foster City, USA). The primer
sequences were:
SST1-forward, 5’-CAGGTTTAAAGAACTGG-
CAAGC-3’,
SST1-reverse 5’-ATTAATAAGCGGCACCATCG-3’,
SST2-forward5’-TCTTTGCTTGGTCAAGGTGA-3’,
SST2-reverse 5’-TCCTGCTTACTGTCGCTCCT -3’
(Microsynth, St. Gallen, Switzerland). Each reaction con-
tained 300 nM of primer. The cycling parameters were
10 min at 95°C, followed by 40 cycles of 15 s at 95°C
and 60 s at 60°C. We calculated relative quantities of
specifically amplified cDNA with the comparative
threshold cycle method. GAPDH acted as an endogen-
ous reference (Microsynth). Template-free and reverse-
transcription-free controls ensured that nonspecific
amplification and DNA contamination could be
excluded.
Preparation of paraffin cochlear sections
Mice were killed with an overdose of sodium pentobar-
bital (100 mg/kg) and transcardially perfused with 50 ml
of phosphate-buffered 4% paraformaldehyde (pH 7.4, at
4°C). The inner ear was carefully removed. Decalcifica-
tion was carried out in a light-protected flask for 10
days in a solution of 120 mM EDTA (Merck, New Jer-
sey, USA) in distilled water (pH 6.8). After decalcifica-
tion, cochleae were prepared for paraffin embedding.
Briefly, cochleae were dehydrated in graded ethanol
solutions (at 70%, 80%, 95%, and 3 × 100% each for 1 h;
3×x y l o lf o r1h ;2×p a r a p l a s ta t- 6 0 ° Cf o r1h ;a n d
paraplast at -60°C for 10 h), and embedded in paraffin
at 56°C. After perfusion, the brain was removed from
the skull and post-fixed overnight.
Histology and Immunocytochemistry
For histological evaluation, cochlear sections of 10 μm
thickness were cut on a Leitz microtome and mounted
on Superfrost plus slides (Menzel, Braunschweig, Ger-
many). Sections were deparaffinized, rehydrated, and
then underwent antigen unmasking by boiling in 10
mM sodium citrate buffer (pH 6.0) and maintenance at
sub-boiling temperature for 10 min. The slides were
then cooled and washed in PBS for 5 min and pro-
ceeded to immunohistochemistry. For histological eva-
luation of the brain, coronal sections of 30 mm
thickness were collected and mounted on Superfrost
plus slides (Menzel, Germany) and dried at room
temperature.
Cells attached to poly-lysine-coated cover slips were
fixed in 4% paraformaldehyde for 15 min, washed twice,
and kept in 0.01 M phosphate-buffered saline (PBS) at
4°C for further processing. After fixation and permeabi-
lization in PBS containing 0.5% Triton X-100 (PBS-T,
pH 8), the vibratome brain sections and cell cultures
were incubated for 1 h at room temperature in blocking
solution containing PBS-T and 3% normal goat serum
(NGS). Microtome sections of mouse cochlea were incu-
bated for 1 h at room temperature in blocking solution
PBS-T containing 5% Triton X-100 (pH 8) and 3% NGS.
The sections and cell culture were incubated with pri-
mary antibody diluted in PBS-T with 1% NGS overnight
at 4°C. The following primary antibodies were used: rab-
bit polyclonal anti-SST1 and anti-SST2 antibodies
(1:400, Gramch Laboratories, Germany), rabbit polyclo-
nal anti-VIIa antibody (1:500, Abcam, UK), mouse
monoclonal anti-calbindin antibody (1:500, Chemicon,
Billerica, USA), mouse monoclonal anti-SMI31 antibo-
dies (1:250, Chemicon, Billerica, USA), and monoclonal
anti-somatostatin antibody (1:250, Santa Cruz Biotech,
California, USA). After 3 washes in PBS-T, the sections
were incubated for 1 h at room temperature with the
appropriate secondary antibodies (1:250, Alexa-conju-
gated, Molecular Probes, Lubio Science, Switzerland)
diluted in PBS-T with 1% NGS for 2 h at room tem-
perature. After washing in PBS, the sections were coun-
terstained with DAPI and mounted on glass slides with
Mowiol.
Slices were visualized on an Olympus AX-70 micro-
scope equipped with a spot digital camera. Recorded
images were adjusted for brightness and contrast with
Image-Pro Plus and Photoshop image processing
software.
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Animals were decapitated and 20 cochleae were care-
fully micro-dissected in ice-cold PBS. The OC was sepa-
rated from the SG and the SV. Brain extract was used
as a positive control. Explants were homogenized in Cel-
Lytic buffer containing protease inhibitor cocktail
(Sigma-Aldrich, St. Louis, USA), and centrifuged. Super-
natants were aspirated and placed in a new tube. Protein
concentration was determined using the BCA Protein
Assay Reagent kit (Pierce, Rockford, USA) according to
the manufacturer’s instructions. Lysates were mixed
with Novex Tricine SDS sample buffer X2 (Invitrogen,
Switzerland) and heated at 95°C for 5 min. Fifty micro-
grams of each lysate was resolved on a Novex Tricine
10% gel; 5 μl of SeeBlue Plus2 Standard (Invitrogen,
Switzerland) were used.
Samples were run at 30 V constant in Novex Tricine
Running Buffer (Invitrogen, Switzerland) until samples
had completely run through the stacking gel and at 100
V constant until the ion front reached the bottom of the
gel (approximately 2 h). The sampels from the tricine
gel were transferred to a polyvinylidene fluoride mem-
brane (Immobilion -P
SQ Millipore, Switzerland). The
transfer was conducted in Novex Tricine Transfer Buffer
(Invitrogen, Switzerland) at 4°C for 2 h at 400 mA con-
stant for 2 gels. The non-specific sites of the transferred
proteins were blocked with blocking solution (1.54 mM
KH2PO4; 155.17 mM NaCl; 2.71 mM Na2HPO4-7H2O,
pH 7.2; 0.1% Tween-20; Roche, Switzerland) diluted
(1:100) in PBS-T for 1 h at room temperature. The
membrane was washed with PBS-T (3 × 10 min) and
then incubated with primary antibodies in 5% non-fat
dry milk in PBS. The following primary antibodies were
used: mouse monoclonal anti-somatostatin (1:1000,
Abcam, UK) and mouse monoclonal anti-b-actin
(1:2000, Santa Cruz Biotech, California, USA). The
membranes were incubated with the primary antibodies
overnight at 4°C.
The blots were washed with PBS-T (3 × 10 min) and
incubated with appropriate HRP-conjugated secondary
antibody for 1 h at room temperature. After washing,
bands were visualized using enhanced chemilumines-
cence (ECL; Amersham Biosciences, Piscataway, USA).
Serial exposures were made to radiographic film (Hyper-
film ECL; Amersham Biosciences).
Statistical Analysis and Software
Since more than two samples were compared, analysis
was performed by the ANOVA test followed by the
Bonferroni post-hoc test. The Origin software (Microcal
Software, Inc., Northampton, MA) was used to generate
graphs and for statistical analysis.
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